Get the latest public health information from CDC.
Get the latest research information from NIH.
NCATS develops novel approaches to improve the process of joining basic science discoveries with initial testing of therapies in humans.
A team of researchers used organoids — tiny 3-D tissue models of human brain development — to better understand brain infections caused by SARS-CoV-2.
NIH-supported preclinical research suggests that the widely used antibiotic methacycline was effective at preventing brain infections and reducing neurological problems associated with the Zika virus.
A new digital book showcases 22 patents issued to NCATS and its collaborators that can help speed the process of translating discoveries into medical interventions. NCATS seeks additional commercial partners to license and use the patents.
Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster.
Discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside.
Developing better model systems for drug and toxicity testing.
Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.
Improving the Drug Development Process
Testing & Predictive Models
Work with Us
NCATS preclinical programs and resources focus on key obstacles and inefficiencies in the translational process, overcoming bottlenecks that slow the development of new treatments for patients.
Learn more about how to access NCATS programs and expertise.
Take a video tour of our labs and see firsthand how our researchers work to get more treatments to more patients more quickly.
Learn more about NCATS’ Achievements in Advancing Translational Sciences.
NCATS Programs & Resources Supporting Preclinical Innovation